NKTX
Nkarta Inc
NASDAQ: NKTX · HEALTHCARE · BIOTECHNOLOGY
$2.69
-2.89% today
Updated 2026-04-29
Market cap
$201.75M
P/E ratio
—
P/S ratio
1,000,000.00x
EPS (TTM)
$-1.41
Dividend yield
—
52W range
$2 – $4
Volume
0.8M
Nkarta Inc (NKTX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+1.2%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-5.7%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-1.6%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-3.3%
2026-03-26
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-26 | $-0.37 | -25.4% | $2.13 | $2.06 | -3.3% |
| 2025-11-05 | $-0.29 | +14.2% | $1.97 | $1.97 | +0.0% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.30 | $-0.37 | -25.4% | — | — |
| 2025-09-30 | $-0.34 | $-0.29 | +14.2% | — | — |
| 2025-06-30 | $-0.35 | $-0.31 | +11.4% | — | — |
| 2025-03-31 | $-0.45 | $-0.43 | +4.4% | — | — |
| 2024-12-31 | $-0.40 | $-0.35 | +12.5% | $9.03M | -14.3% |
| 2024-09-30 | $-0.36 | $-0.39 | -8.3% | — | — |
| 2024-06-30 | $-0.45 | $-0.34 | +24.4% | — | — |
| 2024-03-31 | $-0.56 | $-0.58 | -3.6% | — | — |
| 2023-12-31 | $-0.59 | $-0.57 | +3.4% | $10.54M | — |
| 2023-09-30 | $-0.67 | $-0.52 | +22.4% | — | — |
| 2023-06-30 | $-0.68 | $-0.60 | +11.8% | — | — |
| 2023-03-31 | $-0.70 | $-0.63 | +10.0% | — | — |
Frequently asked questions
Has Nkarta Inc beaten earnings estimates?
Nkarta Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +1.2% over the last 4 quarters.
How does NKTX stock react to earnings?
NKTX stock has moved an average of -1.6% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.